The accumulated expertise among various programs as well as our local partnerships have been the foundation to close such a deal. I’m a true believer that our positioning can be beneficial for other biotech seeking to easily access patient cohorts. Alexis Delbaere Tweet About Cell-Easy Cell-Easy is a science-centric CDMO